The Cardiovascular Research Foundation (CRF) has declared that the New England Journal of Medicine publicised results of the HORIZONS AMI effort which showed the ingest of the medicine bivalirudin mass angioplasty in hunch move patients low gain inauspicious clinical events by 24 proportionality compared to the accepted treatment, as substantially as low the venture of coverall mortality by 33 proportionality and cardiac mortality by 38 percent.The study, led by Gregg Stone, M.D.

Tags: ATM, Heart, Landmark, Led, Medicine, Risk, vascular